Skip to main content

Table 3 CRASH Scoring System

From: The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

Item Score
Diastolic Blood Pressure 0: ≤72 mmHg
1: > 72 mmHg
IADL 0 = 8
1: < 8
LDH 0: ≤ 0.74 x ULN
2: >  0.74 x ULN
ECOG PS 0: 0
1: 1–2
2: 3–4
MMS 0: 30;
2: < 30
MNA 0: 28–30
2: < 28
Chemotherapy risk (MAX2) 0: arm B (FU/LV + Pani)
1: arm A (FOLFOX+Pani)